Mechanisms of disease reversal in focal and segmental glomerulosclerosis

Area of Science:

• Nephrology
• Renal Medicine
• Glomerular Biology

Background:

• Chronic kidney disease (CKD) progression is a significant health concern.
• While interventions can slow CKD, evidence suggests potential for reversal.
• Current therapies, including renin-angiotensin system inhibition, show limitations in reversing glomerular injury.

Purpose of the Study:

• To review the potential for reversing glomerulosclerosis.
• To examine existing evidence from human and animal studies on glomerulosclerosis reversal.
• To discuss underlying mechanisms and future therapeutic strategies.

Main Methods:

• Literature review of studies on glomerulosclerosis reversal.
• Analysis of human and animal data.
• Discussion of biological mechanisms involved in matrix remodeling, capillary reorganization, and podocyte repair.

Main Results:

• Glomerulosclerosis, a key feature of CKD, may be reversible.
• Evidence from human and animal studies supports the potential for regression of glomerular structural injury.
• Mechanisms include matrix remodeling, capillary reorganization, and podocyte reconstitution.

Conclusions:

• Glomerulosclerosis reversal is a potential therapeutic target in CKD.
• Current treatments are insufficient for sustained regression.
• Future strategies should incorporate multi-pronged approaches with novel anti-inflammatory and antifibrotic agents.